期刊文献+

瘦素在非肌层浸润性膀胱癌中的表达及其意义 被引量:2

Expression of Leptin in Non-muscle-invasive Bladder Cancer and Its Significance
原文传递
导出
摘要 [目的]探讨瘦素在非肌层浸润性膀胱癌中的表达情况,组织并分析其与膀胱癌患者临床病理特征及预后的关系。[方法]收集112例膀胱移行细胞癌组织和20例正常膀胱组织的病理切片,采用免疫组化方法检测膀胱癌和正常膀胱组织中瘦素的表达。[结果]正常膀胱组织中瘦素的表达水平明显低于肿瘤组织(P=0.032)。在低级别、高级别膀胱癌中,瘦素的阳性表达率分别为43.8%、75.8%,差别有统计学意义(P=0.001)。本组随访6~102个月,其中67例出现复发。复发组与未复发组中瘦素的阳性表达率分别为70.1%和46.7%,差别有统计学意义(P=0.013)。但瘦素表达与患者年龄、性别、肿瘤数目、大小及分期无明显相关性(P>0.05)。[结论]瘦素表达在膀胱癌组织中明显高于正常膀胱组织,瘦素的检测有助于膀胱癌诊断及预后评估。 [Purpose] To investigate the expression of leptin in non-muscle-invasive bladder cancer and its relationship with clinical features and prognosis. [Methods] The expression of leptin in 112 specimens of non-muscle-invasive bladder cancer and 20 specimens of normal bladder tissues was detected by immunohistochemtry. [Results] The positive rate of leptin was significantly higher in bladder cancer tissues than that in normal bladder tissues (P=0.032). The positive rate of leptin was 43.8% in low grade bladder cancer,75.8% in high grade,with significant difference(P=-0.001). The patients were followed up for 6~102 months,and 67 patients were recurrent. The expression of leptin was significantly higher in recurrence group than that in non-recurrence group (70.1% vs 46.7% ,P=0.013). The positive rate of leptin related to tumor grade and recurrence (P〈0.05),but not with sex,age,tumor number, size and stage (P〉0.05). [Conclusionl The expression of leptin is higher in superficial bladder cancer. The detection of the expression of leptin is helpful to diagnosis and prognostic evaluation in non-muscle-invasive bladder cancer.
出处 《肿瘤学杂志》 CAS 2014年第2期131-134,共4页 Journal of Chinese Oncology
基金 上海市科学技术委员会面上项目(12ZR1417700)
关键词 膀胱肿瘤 瘦素 预后 bladder neoplasms leptin prognosis
  • 相关文献

参考文献4

二级参考文献22

  • 1Henwood M,Clarke PA,Smith MA,et al.Expression of gastrin in developing gastric adenocarinoma.Br J Surg,2001,88:564-568.
  • 2Okada N,Kubota A,Imamura T,et al.Evaluation of cholecystokinin,gastrin,CCK-A receptor,and CCK-B/gastrin receptor gene expressions in gastric cancer.Cancer Lett,1996,106:257-262.
  • 3耿德章.中国老年医学[M].北京:人民卫生出版社,2002.49.
  • 4Esteve J,Benhamou E,Raymond L.Statistical methods in cancer research,Vol Ⅳ-descriptive epidemiology [M].IARC Scientific Publications,No.128,Lyon:IARC,1994.
  • 5McLaughlin JK,Gao YT,Gao RN,et al.Risk factors for renal-cell cancer in Shanghai,China [J].Int J cancer,1992,52(4):562-565.
  • 6Debra TS,Alan SM,Susan SD.Bladder Cancer [A].In:David Schottenfeld,Joseph FF eds.Cancer Epidemiology and Prevention [M].2nd ed.New York:Oxford University Press,1996:1156-1179.
  • 7Johansson SL,Cohen SM.Epidemiology and etiology of bladder cancer [J].Semin Surg Oncol,1997,13(5):291-298.
  • 8Hsing AW,Devesa SS,Jin F,et al.Rising incidence of prostate cancer in Shanghai,China [J].Cancer Epidemiol Biomarkers Prey,1998,7(1):3-84.
  • 9Dennis LK,Resnick MI.Analysis of recent trends in prostate cancer incidence and mortality [J].Prostate,2000,42(4):247-252.
  • 10赵法伋,史奎雄,柳启沛,郭俊生.上海居民膳食结构的变化及食物金字塔[J].中国食物与营养,1997,3(3):27-29. 被引量:4

共引文献71

同被引文献21

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部